Abstract:Objective: To analyze the de novo point mutations in known genes among patients with unexplained intellectual disability (ID) or developmental retardation (DD). Methods: A total of 120 outpatients with ID or DD were recruited in the Department of Neurology, Affiliated Children's Hospital of Capital Institute of Pediatrics between September 2015 and April 2017. Target gene sequencing was used to screen the candidate gene. The sequencing data were analyzed by a variety of bioinformatics software. Combining with the phenotypes of the patients, the candidate genetic/genomic variants were identified from next-generation sequencing data. The final pathogenicity of the genetic/genomic variants were interpreted according to the guideline of the American College of Medical Genetics and Genomics (ACMG) for variants after segregation analysis in the parents and necessary family members by Sanger sequencing. The comprehensive physiological function and signaling pathways of 20 disease genes with de novo point mutation discovery was also studied. Results: Among the 120 patients, 23 patients were found to carry clear pathological changes, and the incidence of de novo point variation was 19.2%. The patients included 12 males and 11 females, with an age of 2 months to 6-year-6-month. Five patients were diagnosed with early onset of epileptic encephalopathy. Seven had mental retardation type 5, 6, 8, 19, 20, 22, 39, respectively. Weill-Marchesani syndrome type 2 was found in one case, Wiedemann-Steiner syndrome in one case, Coffin-Siris syndrome in two cases, Rubinstein-Taybi syndrome in one case, GLUT1 deficiency syndrome in one case, Rett syndrome in one case, cardio-facio-cutaneous syndrome 3 in one case, neurodegeneration with brain iron accumulation in one case, corpus callosum local dysplasia in one case, and congenital fibrosis of the extra-ocular muscles in one case. A total of 20 novel mutations were reported in this study. No somatic mutation was found in the samples of 6 patients with mutation and their parents' peripheral blood DNA samples by amplicon-based deep sequencing. This study found that the main disease genes were involved in chromatin remodeling, transcriptional regulation, autophagy body assembly, MAPK signal pathway, DNA methylation, potassium, sodium ion transport, cell skeleton assembly and skeletal muscle development. These genes were significantly enriched in the following biological processes: Ras signaling pathways, transcription factor binding and cancer related signaling pathway. Conclusions: The etiology of children affected with intellectual disability or developmental delay is complex. Harmful de novo point mutation plays an important role in these diseases. Targeted exome/genome sequencing based on the core family is helpful for the molecular diagnosis of patients and the discovery of more genes.

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

[Gene Screening in Five Chinese Families with Hereditary Spastic Paraplegia with Thin Corpus Callosum].

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Compound Heterozygous Mutation of the SNX14 Gene Causes Autosomal Recessive Spinocerebellar Ataxia 20

Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene

Identification of Two Novel MYH3 Variants Causing Different Phenotypes in Prenatal Diagnosis.

Polymelia Treatment, Whole-Exome Sequencing and Disease Network Analysis

Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family

Identification Of Pathogenic Mutations In 6 Chinese Families With Multiple Exostoses By Whole-Exome Sequencing And Multiplex Ligation-Dependent Probe Amplification Case Series

Genetic Analysis and Prenatal Diagnosis in a Chinese with Growth Retardation, Abnormal Liver Function, and Microcephaly

Molecular diagnosis of patients with syndromic short stature identified by trio whole-exome sequencing

A pilot study of gene testing of genetic bone dysplasia using targeted next-generation sequencing

Identification and analysis of the genetic causes in nine unrelated probands with syndromic craniosynostosis.

[Study of de novo point mutations in known genes among patients with unexplained intellectual disability or developmental delay]

Causal Variants Screened by Whole Exome Sequencing in a Patient with Maternal Uniparental Isodisomy of Chromosome 10 and a Complicated Phenotype

Genetic studies of 77 cases of short stature with unknown etiology

Genetics Evaluation of Targeted Exome Sequencing in 223 Chinese Probands with Genetic Skeletal Dysplasias.

Identification of the Genetic Basis of Sporadic Polydactyly in China by Targeted Sequencing

Genetic Heterogeneity in Four Probands Reveals HGSNAT, KDM6B, LMNA and WFS1 Related Neurodevelopmental Disorders

Exome sequencing revealed<i> USP9X</i> and<i> COL2A1</i> mutations in a large family with multiple epiphyseal dysplasia

Detection of Mutations in Lrpap1, Ctsh, Leprel1, Znf644, Slc39a5, and Sco2 in 298 Families with Early-Onset High Myopia by Exome Sequencing